Virtual screening based identification of miltefosine and octenidine as inhibitors of heat shock protein 90
- 18 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 394 (11), 2223-2232
- https://doi.org/10.1007/s00210-021-02133-y
Abstract
The molecular chaperone HSP90 facilitates the maturation of newly synthesized and unfolded proteins. The client proteins of HSP90 are involved in many processes of cancer occurrence and development, and therefore, HSP90 is considered as a promising target for the development of anticancer drugs. In contrast to N-terminal inhibitor, C-terminal inhibitor does not induce the pro-survival heat shock response. In order to get novel HSP90 C-terminal inhibitors and more evidences that HSP90 inhibitors could be applied in the therapy of cancer, we conducted a virtual screening toward HSP90 C-terminus from FDA-approved drugs. In this study, miltefosine and octenidine were identified as new HSP90 inhibitors. Miltefosine and octenidine exhibited strong and broad-spectrum anticancer activity and inhibited the proliferation of cancer cell by promoting apoptosis. Western blotting analysis revealed that miltefosine and octenidine significantly down-regulated the expression levels of HSP90 client proteins including p-AKT, CDK6, and ERK, and did not induce overexpression of heat shock proteins including HSP70 and HSP90 in MCF-7 cells. These results were in accordance with the characteristics of HSP90 C-terminal inhibitor. In conclusion, miltefosine and octenidine could disrupt the molecular chaperone function of HSP90, and thus, their strong and broad-spectrum anticancer activity is at least in part attributed to the inhibition activity against HSP90.Keywords
Funding Information
- Natural Science Foundation of Liaoning Province (2020-MS-105)
- Fundamental Research Funds for the Central Universities (DUT20LK20)
This publication has 35 references indexed in Scilit:
- Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell linesCancer Cell International, 2013
- Hsp90 Inhibitors as Anti-Cancer Agents, from Basic Discoveries to Clinical DevelopmentCurrent Pharmaceutical Design, 2013
- HSP90 as a platform for the assembly of more effective cancer chemotherapyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic EmergesPharmaceuticals, 2011
- Dynamics-Based Discovery of Allosteric Inhibitors: Selection of New Ligands for the C-terminal Domain of Hsp90Journal of Chemical Theory and Computation, 2010
- HSP90 at the hub of protein homeostasis: emerging mechanistic insightsNature Reviews Molecular Cell Biology, 2010
- Octenidine Dihydrochloride, a Modern Antiseptic for Skin, Mucous Membranes and WoundsSkin Pharmacology and Physiology, 2010
- Modulation of Hsf1 activity by novobiocin and geldanamycinBiochemistry and Cell Biology, 2009
- Structural Models and Binding Site Prediction of the C‐terminal Domain of Human Hsp90: A New Target for Anticancer DrugsChemical Biology & Drug Design, 2008
- Navigating the Chaperone Network: An Integrative Map of Physical and Genetic Interactions Mediated by the Hsp90 ChaperoneCell, 2005